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Abstract 
Chronic obstructive pulmonary disease (COPD) is one of the most common causes of morbidity and mortality 
worldwide. Patients with COPD experience a succession of distressing physical, psychological and social 
changes. Currently, there is no cure for COPD or its debilitating effects on pulmonary function. As a result, 
health care professionals have shifted their focus from reversing the disease process to reducing disability and 
improving QOL. The study was to assess the impact of pulmonary rehabilitation program on health outcomes of 
patients with COPD. The study was conducted in the chest diseases department of Mansoura University 
Hospital. A total of 27 COPD patients were enrolled in the study. They received the two- month home-based 
pulmonary rehabilitation program in addition to usual hospital care. The health outcomes were measured by five 
tools; Saint's George Respiratory Questionnaire (SGRQ), six minutes walk test, Modified Borg Dyspnea Scale 
and pulmonary function test.  The study revealed that, only activity dimension of SGRQ improved significantly 
in patients with both moderate and severe disease stages while patients with very severe stage showed significant 
improvement in all dimensions of SGRQ except symptoms dimention.  There was no significant improvement in 
pulmonary function tests of patients in three disease stages. Functional capacity and perceived exertional 
dyspnea were significantly improved for patients in the moderate and severe stages, while very severe stage 
patients showed significant improvement only in perceived dyspnea. The supervised two- month home-based 
pulmonary rehabilitation program is an effective non pharmacological intervention in the management of 
moderate, severe and very severe stable COPD patients. 
Keywords: Pulmonary rehabilitation; Quality of Life; health outcomes; COPD stages. 
 
Introduction 
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant 
extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is 
characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive 
and associated with an abnormal inflammatory response of the lung to noxious particles or gases (GOLD, 2010). 
COPD is composed primarily of two related diseases; chronic bronchitis and emphysema. Most COPD patients 
have one predominant disease entity, but often with manifestation of both (Hogg, 2004). 
COPD is one of the leading causes of mortality and disability both in developed and developing countries (Anto 
et al., 2001). It is ranked the fourth cause of death worldwide. Furthermore, it is currently the twelfth leading 
cause of disability worldwide (Ait-Khaled et al., 2001). The World Health Organization (WHO) estimated that 
by the year 2020 COPD will be the third leading cause of death and the fifth cause of disability worldwide 
(Barnes, 2002).  
Patients with COPD experience a succession of distressing physical and psychosocial changes that affect 
significantly QOL (Peruzza et al., 2003). Physically, dyspnea, cough, fatigue and sleep disturbance are the most 
common problems associated with COPD and contributor to disability and poor QOL through the limitations 
they impose on motivation, concentration and everyday activities including household chores and social and 
leisure pastimes. Psychosocially, feeling of depression and anxiety are frequently reported by patients with 
COPD. Also COPD is associated with several social problems as loss of social role and a tendency to avoid 
social interaction and recreational activities. These problems influence physical functioning, independency, 
perceived wellbeing, health outcomes and overall QOL in subtle and complex ways (McCann & Moreau, 2003; 
Yohannes, 2005; Barnet, 2008). Since medications do not eliminate all of the symptoms of COPD and a cure of 
the illness is not possible, pulmonary rehabilitation has been employed to improve exercise tolerance, functional 
capacity and QOL (Weaver et al., 1997). 
Pulmonary rehabilitation is a multidimensional continuum of services directed to persons with pulmonary 
diseases with the goal of achieving and maintaining the individual's maximum level of independence and 
functioning in the community. Pulmonary rehabilitation can change outcomes that predict survival and can 
improve the systemic component of COPD and its comorbidities with a potential effect on survival (Hunter & 
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King, 2001). The appropriate selection of patients plays a key role in the success of pulmonary rehabilitation 
(Bourbeau et al., 2003). Appropriate patients for pulmonary rehabilitation programs are those who recognize that 
their symptoms depend upon their lung disease and are motivated to be active participants in their own care to 
improve their health status. The only absolute contraindications are a long history of lack of compliance and 
unwillingness to participate. Excellent evidence supports the benefits of pulmonary rehabilitation in stable 
patients (Norweg et al., 2005; Ries et al., 2007; Maltais et al., 2008). Nevertheless, it is not yet widely utilized in 
many developing countries (Al Moamary, 2008). GOLD (2010) recommended pulmonary rehabilitation for 
COPD patients from stage II (FEV1 < 80%) and physician referrals to this intervention generally include late 
stages of the disease (Ambrosino & Simonds, 2007; Romagnoli et al., 2006).Therefore, the aim of this study was 
to assess the impact of pulmonary rehabilitation program on health outcomes of patients with moderate and 
severe COPD. 
 
Materials and method 
Design: Quasi-experimental research design was used in this study. 
Settings:  
This study was carried out at the chest diseases department of Mansoura University Hospital, Egypt. 
Subjects:  
The study subjects comprised all COPD patients of both sexes admitted to the above mentioned setting 
during a period of three months and fulfilling the following criteria: clinically stable with no exacerbation in the 
last month, Had COPD diagnosed according to the criteria of Gold (2010)
 (1)
, had COPD staged according to 
GOLD 2010
(1)
; Stage 2: moderate COPD (50% ≤ FEV1 < 80% predicted) and stage 3: sever COPD (30% ≤ 
FEV1 < 50% predicted), and free from any other respiratory or associated disorders as heart failure, coronary 
artery diseases and asthma. Their number amounted to 27 COPD patients.  
Study Tools:  
Five tools were utilized for the purpose of data collection. 
Tool I: Structured Interview Schedule:  
It was developed by the researchers and concerned with biosocio-demographic characteristics of the study 
sample, medical history and patient exposure to risk factors as smoking, environmental and occupational 
exposures.  
Tool II: Saint's George Respiratory Questionnaire (SGRQ) (Jones et al., 1992):  
The SGRQ was developed by Jones, 1992 to measure health related quality of life in patients with COPD. 
It provides an overall measure for the quality of life with subscale scores in three dimensions: symptoms, 
activities and impact of disease on daily life. The symptoms subscale is concerned with the effect, frequency 
and severity of respiratory symptoms as regard cough, sputum, dyspnea and wheeze. Activity subscale focuses 
on physical activities that either cause or are limited by breathlessness. Impacts subscale covers a range of 
aspects concerned with social functioning and psychological disturbances resulting from airways disease. Each 
subscale of the questionnaire is scored between 0% (no impairment) and 100% (maximal impairment). A 
cumulative score for the whole questionnaire also ranges between 0% (no impairment) and 100% (maximal 
impairment).  
Tool III: Pulmonary Function Test:  
It was used to evaluate the obstructive ventilatory defect. Three parameters were measured: Forced 
Expiratory Volume in 1 second (FEV1), Forced vital capacity (FVC) and the ratio between Forced Expiratory 
Volume in 1 second and Forced Vital Capacity (FEV1/FVC). These parameters were measured by the spirometer 
(spirolab II, Rome, Italy). The results were then expressed as percentage of predicated normal values for each 
subject after adjustment for age, sex and height 
(20)
. 
Tool IV: Six minutes walk test (6 MWT) (ATS, 2002):  
It is a global objective indicator of functional capacity. It is used by measuring the distance (by miters) 
that the patient covered in 6 minutes. The patients were instructed to cover as much distance as possible in the 6 
minutes and verbal encouragement every minute was given. The test was completed in a 50-miters flat corridor 
inside the department. Patients’ walked distance pre and post program were compared.  
Tool V: Modified Borg Dyspnea Scale (Borg, 1982):  
Modified Borg Scale is a numerical scale for rating perceived dyspnea immediately after a 6 minutes 
walk test. Patient was instructed to indicate the level of his dyspnea on a 10-point horizontal line after 6minutes 
of walking. Higher score indicates severe dyspnea. Ratings pre and post program were compared.  
 
Method 
1. Permission to carry out the study was obtained from the responsible authorities at the chest diseases 
department of Mansoura University Hospital after explanation of the aim of the study.  
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2. Tool II (Saint's George Respiratory Questionnaire) and tool IV (Modified Borg Scale) were translated into 
Arabic by two researchers and back-translated into English by the other two researchers. The required 
corrections and modifications were carried out accordingly. 
3. Tool II and IV were tested for their reliability. Test-retest measurement was used. Tools were applied on 10 
COPD patients selected from chest diseases department. Tools were repeated again for these patients after 
two weeks. The reliability was assured by means of Cronbach’s coefficient alpha. It indicated that the tools 
have a reliability of 0.86 and 0.88 respectively.   
4. Verbal consent from the patients to participate in the study was obtained after explanation of the study 
purpose and its potential benefits.  
5.  Privacy of the study sample and confidentiality of the collected data were assured throughout the study. 
6. A pilot study was conducted on 5 COPD patients from chest diseases department of Mansoura University 
Hospital in order to evaluate the clarity and applicability of the tools. These patients were not included in the 
study sample. Following this pilot study, the final form of tools were reconstructed and made ready for use.  
7. For proper conduction of the study, Three phases were utilized:  
Assessment Phase:  
• Chest radiograph report, chest computed tomography report and electrocardiogram (ECG) for 
each patient were revised by the researcher to confirm the diagnosis and exclude any 
coexisting lung pathology or complications. 
• Each patient was interviewed individually at chest diseases department on their admission to 
collect the baseline patient’s data using all study tools (I, II, III, IV and V). 
Intervention phase: 
Pulmonary rehabilitation program 
The program was developed by the researcher based on review of current literature 
(23-30)
 and the 
rehabilitative needs of each patients identified from assessment phase of the study. A booklet containing the 
components of the program was designed and written in a simple Arabic language and supplemented by photos 
and illustrations and was given to each patients and used as a reminder to support teaching and practicing at 
home. Simple audio-visual materials were designed by the researcher to facilitate transmission of ideas and keep 
interest of the study group during sessions.  During the hospitalization period, the developed pulmonary 
rehabilitation program was conducted in 8 sessions over 2 weeks. Each session took about 30 minutes. The 
developed pulmonary rehabilitation program was conducted in small groups (3-5 patients/session). Each patient 
was subjected to two types of sessions: theoretical and practical sessions. 
1. Theoretical sessions: were carried out in 4 sessions. They included information about the following: 
• Respiratory system and COPD nature. 
• COPD medications. 
• Behavior and lifestyle modification related to proper nutrition, energy conversation techniques, 
healthy sleep, dyspnea management, measures to reduce risk of infection and airway irritants, 
smoking cessation, periodic medical follow up and exercises. 
2. Practical sessions: they carried out in 4 sessions. Patients were taught to perform these exercises and 
instructed to do them at home after discharge from the hospital for 2 months. Practical sessions included 
the following: 
• Inspiratory muscle training by using incentive spirometery 
• Breathing retraining (pursed lip breathing and diaphragmatic breathing) 
• Stretching and strengthening   exercise for upper and lower extremities with using dumbbells (1 and 
2 Kgs).   
•  Airway clearance techniques (deep breathing and coughing exercise and chest percussion and 
vibration). 
• Telephone visits were provided twice a week during 2 months post discharge by the researcher for patients to 
check with them their consistency with program. Problems and concerns in performing the program were 
discussed. 
Evaluation phase: 
• 2 and 6 months post discharge from the hospital, each patient was evaluated to determine the effect of 
program on QOL, pulmonary function, functional capacity, and perceived dyspnea using the study tools: II, 
III, and VI. 
Statistical analysis: 
• Data was analyzed using computer with statistical package for social science (SPSS) version 15. The 0.05 
level was used as the cut off value for statistical significance and the following statistical measures were 
used: descriptive statistics, analytical statistics and graphical presentation.  
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Results 
Table 1. Socio-demographic characteristics of the moderate, severe and very severe COPD stages:  
 
Items 
Moderate stage Severe stage Very severe stage Pearson Chi-
Square χ
2
 test 
(P) N= (8) % N= (16) % N= (8) % 
Age (in years) 
  
40- 
 55- 
 70+ 
 
2 
2 
4 
 
25.0 
25.0 
50.0 
 
6 
8 
2 
 
37. 5 
50.0 
12.5 
 
 
1 
1 
1 
 
 
33.3 
33.3 
33.3 
 
 
1.964 (0.742) 
Sex 
 Male 
 female 
 
7 
1 
 
87.5 
12.5 
 
14 
2 
 
87.5 
12.5 
 
2 
1 
 
66.7 
33.3 
 
0.917 (0.632) 
Marital status 
 Married 
 Single 
 Divorced 
 
6 
2 
0 
 
75.0 
25.0 
0.0 
 
14 
1 
1 
 
87.5 
6.3 
6.3 
 
2 
1 
0 
 
66.7 
33.3 
0.0 
 
2.928 (0.570) 
Educational level 
 Read and write 
 Primary   
 Secondary  
University 
 
1 
1 
4 
2 
 
12.5 
12.5 
50.0 
25.0 
 
2 
1 
3 
10 
 
12.5 
6.25 
18.75 
62.5 
 
2 
0 
0 
1 
 
66.7 
0.0 
0.0 
33.3 
 
 
12.150 (0.275) 
 
Table (1) revealed that, 50.0 % of the moderate stage were 70 years old and more and 50.0 % of the severe stage 
were 55 to less than 70 years. Males were more prevalent in the moderate, severe, and very severe stage. 87.5% 
of the patients were male and at the moderate stage of the disease. The majority of the patients in the moderate, 
severe and very severe stages were married (75.0%, 87.5 % and 66.7% respectively). There were no statistical 
significant differences were detected regarding socio-demographic characteristic of the patients. 
 
Table 2. Stages of COPD as presented by patients at 3 different intervals (pre, 2 and 6 months post pulmonary 
rehabilitation program): 
 
Items 
Moderate COPD 
 
(50%≤ FEV1< 80% 
predicted) 
Severe COPD 
 
(30%≤FEV1<50% 
predicted) 
Very severe COPD 
 
(FEV1< 30% predicted) 
NO % NO % NO % 
Pre-rehab. 8 29.6 16 59.3 3 11.1 
2 months 
Post rehab. 
(post 1) 
9 33.3 15  55.6 3 11.1 
6 months 
Post rehab. 
(post 2) 
10 37.0 14 51.9 3 11.1 
Z Test (P)
1
 1.000 (0.317) 
 Z Test (P)
2
 1.414 (0.157) 
Wilcoxon Signed Ranks Z Test (P)
1
: comparing pre-rehab and 2 months post-rehabilitation (post 1).  
Wilcoxon Signed Ranks Z Test (P)
2
: comparing pre-rehab and 6 months post-rehabilitation (post 2).  
*Significant, at P≤ 0.05.  
Table (2) describes stages of COPD pre, 2 months and 6 months post pulmonary rehabilitation. The results 
revealed that there were no statistical significant differences were detected among patients in the 3 stages of 
severity. 
 
 
Journal of Education and Practice                                                                                                                                                      www.iiste.org 
ISSN 2222-1735 (Paper)   ISSN 2222-288X (Online) 
Vol.4, No.15, 2013 
 
82 
Table 3. Effect of pulmonary rehabilitation program on quality of life of patients at 3 levels of disease severity   
(Moderate, severe and very severe): 
 
Quality 
 of  
life 
(SGRQ)
#
 
Moderate COPD Severe COPD 
 
Very severe COPD 
F 
 (P)
a
 
F 
(P)
b
 
F 
(P)
c
 
Pre-rehab. 
 
 
N=8 
2 months 
Post rehab. 
(post 1) 
N=9 
6 months 
Post 
rehab. 
(post 2) 
N=10 
Pre-rehab. 
 
 
N=16 
2 months 
Post rehab. 
(post 1) 
N=15 
6 months 
Post rehab. 
(post 2) 
N=14 
Pre-rehab. 
 
 
N=3 
2 months 
Post rehab. 
(post 1) 
N=3 
6 months 
Post rehab. 
(post 2) 
N=3 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
Symptoms 40.68 ±5.55 36.00± 5.43 36.01± 
5.25 
63.56±12.45 59.31±14.92 61.98±14.41 85.00±11.00 79.73±13.15 79.73±13.15 21.753 
(0.000)* 
17.273 
(0.000)* 
22.278 
(0.000)* 
t-test (P)
1
 1.753 (0.100) 0.864 (0.394) 2.623 (0.120) 
t-test (P)
2
 1.826 (0.087) 0.323 (0.749) 2.623 (0.120) 
Activities 41.83 ±5.06 32.04± 9.95  36.03± 
12.36 
58.80±12.48 47.74±11.43 50.96±14.52 74.36±10.61 61.75±4.16 64.25±6.92 11.989 
(0.000)* 
11.046 
(0.002)* 
6.598 
(0.005)* 
t-test (P)
1
   2.505 (0.024)* 2.569 (0.016)* 2.021 (0.181) 
t-test (P)
2
 1.348 (0.202) 1.590 (0.123) 4.638 (0.043)* 
impact 45.36±11.67 34.48±13.09 33.23± 
14.31 
59.51±10.50 52.63± 9.80 52.22±11.26 71.84±3.59 63.65±2.02 62.53±3.03 8.403 
(0.002)* 
11.903 
(0.001)* 
10.219 
(0.001)* 
t-test (P)
1
 1.799 (0.092) 1.885 (0.070) 4.704 (0.042)* 
t-test (P)
2
 1.934 (0.071) 1.834 (0.077) 5.260 (0.034)* 
Total  43.47±8.47 34.01± 9.98 34.54 
±11.01 
59.97±10.67 52.29±10.27 53.51±12.05 74.90±5.64 65.86±4.12 66.01±5.70 13.545 
(0.000)* 
15.567 
(0.000)* 
12.663 
(0.000)* 
t-test (P)
1
 2.094 (0.054) 2.038 (0.051) 9.629 (0.011)* 
t-test (P)
2
 1.888 (0.077) 1.557 (0.131) 9.612 (0.011)* 
Paired –sample t-test (P)
1
: comparing pre-rehab and 2 months post-rehabilitation (post 1) in each stage.  
Paired –sample t-test (P)
2
: comparing pre-rehab and 6 months post-rehabilitation (post 2) in each stage. 
Anova test  (P)
a
: comparing between stages pre-rehab. 
Anova test  (P)
b
: comparing between stages 2 months post-rehab. (post 1). 
Anova test  (P)
c
: comparing between stages 6 months post-rehab. (post 2). 
# 
Saint's George Respiratory Questionnaire (decreased
 
scores denote improvement).       
*Significant, at P≤ 0.05 
Table (3) showed that the total score for all QOL dimensions such as symptoms, activities, and impact decreased 
(improved) in moderate, severe and very severe stages of disease at 2 and 6 months post rehabilitation program. 
The improvement was statistically significant for activities dimension (for the three stages), for impact 
dimension and total score (only for very severe stage).  
Table 4. Effect of pulmonary rehabilitation program on functional capacity and perceived dyspnea of patients at 
3 levels of disease severity (moderate, severe and very severe): 
  
Items 
Moderate COPD Severe COPD Very severe COPD 
F 
 (P)
a
 
F 
(P)
b
 
F 
(P)
c
 
Pre-rehab. 
 
N=8 
2 months 
Post rehab. 
(post 1) 
N=9 
6 months 
Post rehab. 
(post 2) 
N=10 
Pre-rehab. 
 
N=16 
2 months 
Post rehab. 
(post 1) 
N=15 
6 months 
Post rehab. 
(post 2) 
N=14 
Pre-rehab. 
 
 
N=3 
2 months 
Post rehab. 
(post 1) 
N=3 
6 months 
Post rehab. 
(post 2) 
N=3 
Mean 
± 
SD 
Mean 
± 
SD 
Mean 
± 
SD 
Mean 
± 
SD 
Mean 
± 
SD 
Mean 
± 
SD 
Mean±SD Mean±SD Mean±SD 
functional 
capacity 
6MWT (miter) 
351.63 
± 
21.02 
400.11 
± 
26.68 
390.40 
± 
27.25 
262.31 
± 
39.96 
310.33 
± 
47.35 
293.21 
± 
45.34 
217.67 
± 
2.52 
258.67 
± 
22.81 
253.33 
± 
28.43 
25.413 
(0.000)* 
20.382 
(0.000)* 
24.780 
(0.000)* 
t-test (P)
1
 4.122 (0.001)* 3.059 (0.005)* 2.827 (0.106) 
t-test (P)
2
 3.307 (0.004)* 1.985 (0.057)  2.030 (0.180) 
perceived 
dyspnea  
(Borg Scale)
#
 
2.00 
± 
0.93 
1.00 
± 
0.00 
1.60 
± 
0.70 
6.00 
± 
2.00 
3.80 
± 
2.08 
4.93 
± 
1.69 
9.00 
± 
0.00 
5.33 
± 
1.15 
6.67 
± 
0.58 
24.620 
(0.000)* 
11.777 
(0.000)* 
25.909 
(0.000)* 
t-test (P)
1
 3.055 (0.018)* 3.004 (0.005)* 5.500 (0.032)* 
t-test (P)
2
 1.046 (0.311) 1.574 (0.127)  7.000 (0.020)* 
Paired –sample t-test (P)
1
: comparing pre-rehab and 2 months post-rehabilitation (post 1) in each stage.  
Paired –sample t-test (P)
2
: comparing pre-rehab and 6 months post-rehabilitation (post 2) in each stage. 
Anova test  (P)
a
: comparing between stages pre-rehab. 
Anova test  (P)
b
: comparing between stages 2 months post-rehab. (post 1). 
Anova test  (P)
c
: comparing between stages 6 months post-rehab. (post 2). 
# 
decreased
 
scores denote improvement.           
*Significant, at P≤ 0.05 
 
Table (4) shows the functional capacity and perceived dyspnea of patients at 3 levels of disease severity 
(moderate, severe and very severe) pre and at 2 and 6 months post pulmonary rehabilitation program. Both 
moderate and severe disease stages showed improvement in functional capacity and perceived exertional 
dyspnea at 2 and 6 months post rehabilitation program and the improvement reached a statistically significant 
level at both stages of severity, while very severe stage showed significant improvement only in perceived 
dyspnea.  
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Table 5. Effect of pulmonary rehabilitation program on pulmonary function tests of patients at 3 levels of disease 
severity   (moderate, severe and very severe): 
Pulmonary 
function tests 
Moderate COPD Severe COPD 
 
Very severe COPD 
F 
 (P)
a
 
F 
(P)
b
 
F 
(P)
c
 
Pre-rehab. 
 
 
N=8 
2 months 
Post rehab. 
(post 1) 
N=9 
6 months 
Post rehab. 
(post 2) 
N=10 
Pre-rehab. 
 
 
N=16 
2 months 
Post rehab. 
(post 1) 
N=15 
6 months 
Post rehab. 
(post 2) 
N=14 
Pre-rehab. 
 
 
N=3 
2 months 
Post rehab. 
(post 1) 
N=3 
6 months 
Post rehab. 
(post 2) 
N=3 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
FVC (% Pred.) 81.80±7.89 84.38± 7.19 83.95± 6.89 66.78±8.70 68.16±10.13 66.36 ±9.32 56.87±9.38 56.23±6.43 56.00±6.25 12.333 
(0.000)* 
14.560 
(0.000)* 
19.362 
(0.000)* t-test (P)
1
 0.705 (0.492) 0.407 (0.687) 0.293 (0.707) 
t-test (P)
2
 0.617 (0.546) 0.127 (0.900) 0.313 (0.784) 
FEV1 (% Pred.) 63.20±8.25 62.87± 9.13 61.06±9.25 38.80±6.53 38.84 ±6.95 37.82±6.65 27.17±3.09 26.80±1.71 26.53±0.50 44.592 
(0.000)* 
39.381 
(0.000)* 
38.568 
(0.000)* t-test (P)
1
 0.079 (0.938) 0.017 (0.987) 0.382 (0.739) 
t-test (P)
2
 0.511 (0.616) 0.406 (0.688) 0.417 (0.717) 
FVC/FEV1 
(%Pred.) 
63.14±4.07 64.37±4.98 64.06±5.14 55.64 ±2.12 56.80± 2.99 55.66± 2.39 
47.57±3.44 47.60±1.87 47.33±2.36 34.723 
(0.000)* 
25.717 
(0.000)* 
29.115 
(0.000)* 
t-test (P)
1
 0.553 (0.589) 1.249 (0.222) 0.034 (0.976) 
t-test (P)
2
 0.414 (0.685) 0.016 (0.987) 0.157 (0.890) 
Paired –sample t-test (P)
1
: comparing pre-rehab and 2 months post-rehabilitation (post 1) in each stage.  
Paired –sample t-test (P)
2
: comparing pre-rehab and 6 months post-rehabilitation (post 2) in each stage. 
Anova test (P)
a
: comparing between stages pre-rehab. 
Anova test (P)
b
: comparing between stages 2 months post-rehab. (post 1). 
Anova test (P)
c
: comparing between stages 6 months post-rehab. (post 2). 
*Significant, at P≤ 0.05 
Table (5) shows pulmonary function tests of patients at 3 levels of disease severity (moderate, severe and very 
severe) pre and at 2 and 6 months post pulmonary rehabilitation program. Post pulmonary rehabilitation, both 
FVC and FVC/FEV1 had slightly improved in both moderate and severe disease stage while FEV1 improved 
only in the severe disease stage but these improvements did not reach a statistically significant level. Very severe 
stage had lower pulmonary function values both at 2 and 6 months post rehabilitation. 
 
Discussion 
Chronic obstructive pulmonary disease is a disease that is not confined to airways and the lungs, but also 
produces systemic consequences so a multidisciplinary approach must be taken into account. Although there are 
a variety of drugs that reduce the symptoms of COPD, there is still no treatment that can restore pulmonary 
functions to a normal, predisease level (GOLD, 2010). Pulmonary rehabilitation is recognized as a cornerstone 
of COPD treatment: it ameliorates symptoms and exercise capacity, improving health-related quality of life. In 
the present study the comparison between the outcomes of pulmonary rehabilitation in moderate, severe and very 
severe stage of COPD was done. 
The results of the current study revealed that, there was marked improvement in QOL but this improvement was 
still out of significance except for activity dimension for moderate and severe stage, while very severe stage 
showed significant improvement in all dimensions of SGRQ except for symptoms. Clearly, mechanisms that 
explain improved QOL after pulmonary rehabilitation program go beyond exercise physiology and include 
improved mood state and increased self-efficacy and confidence. The same results were confirmed in a study 
conducted in Turkey by Ergün et al (2011), they found that comprehensive pulmonary rehabilitation program in 
an outpatient setting showed significant improvement in QOL and the improvement reached a statistically 
significant level and patients had benefited from a program regardless of disease severity. On the other hand, 
Wedzicha et al (1998) in UK, however, did not find that QOL improved in COPD patients who followed a home 
–based pulmonary rehabilitation program, even though the patients were supervised by a physical therapist and 
attributed the lack of benefit to the short duration of the program, the severity of disease and the low intensity of 
exercise. This is in congruence with a study done in The Netherlands by Hesselink et al (2004) they reported that 
rehabilitation program, provided by a general practice assistant for patients with asthma and COPD resulted in an 
improved inhalation technique however it did not show any change in disease symptoms or QOL. They 
interpreted the result that the participants had mild to moderate symptoms and generally good QOL scores at 
baseline.  
Additionally, the present study showed that, both FVC (% Pred.) and FVC/FEV1 (% Pred.) improved in both 
moderate and severe stage disease while FEV1 improved only in the severe disease stage but the improvement 
not reach statistically significant level. This is in accordance with Niederman et al (1991) in USA, Vogiatzis et al 
(1991) in UK and Karapolat et al (2007) in Turkey who demonstrated that the training benefits of rehabilitation 
are independent of underlying airflow limitation and rationalized that COPD is a chronic and progressive disease 
that results in no improvement in pulmonary function and arterial oxygenation with rehabilitation program.  
As regard functional capacity, the present study revealed that, walking distance during six minutes time 
increased significantly after program implementation for both moderate and severe COPD stages denoting 
functional capacity improvement. This improvement may be attributed to several factors. The first is related to 
improvement in lung function parameters. The second mechanism, as demonstrated by various authors, points to 
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an effect of muscle training on neuromuscular coordination (Resqueti et al., 2007). Improvement in this respect 
would increase an individual’s ability to carry out activities of daily living, particularly for the most sedentary 
patients.  The third mechanism to which improved functional capacity in COPD patients is attributed to 
desensitization of dyspnea during exercise and development of tolerance which may enable patients to perform 
higher level of work with reduced symptoms (Celli, 2000). Finally the fact that patients in the current study 
participated in a pulmonary rehabilitation program that included the training of different muscle groups may be 
additional factor that explains the good response observed. Very severe stage showed improvement in their 
achieved distance but the improvement did not reach statistically significant level. This may attributed to the 
limited number of patients with very severe COPD. 
Concerning the perception of exertional dyspnea, the results of present study revealed that patients in three 
stages showed significant decrease (improvement) in their ratings of perceived dyspnea. The possible 
mechanisms for reduced severity of breathlessness are: increased in lactate threshold, improved skeletal muscle 
oxidative activity, corresponding fall in ventilatory demands during exercise as a result of enhanced mechanical 
efficiency and improved respiratory muscle function (Casaburi  et al.,1997; Lotters et al., 2002).This is in 
agreement with the previous studies in this field (Nield et al., 2007; person et al., 2000).  
The severe disease stage gained greater improvement in activity dimension of QOL and perceived dyspnea while 
very severe stage showed significant improvement in impact and total score of SGRQ. Moderate stage gained 
greater improvement in functional capacity. This could be due to the larger room for improvement that these 
patients (severe and very severe COPD stage) may have from a pulmonary rehabilitation program: they are often 
more home bound, have greater limitation to exercise, and suffer from greater dyspnea. These results are in 
accordance with a study done in France by Beaumont et al (2011) who concluded that all participants benefited 
from rehabilitation and the most severe benefited the most.  
On the other hand, Takigawa et al  (2007)  in Japan  found that late stage COPD (severe and very severe COPD) 
showed marked improvement in pulmonary functions, functional capacity and arterial blood gases than early 
stage (mild and moderate COPD). In the same line, Altenburg et al (2011) in The Netherlands concluded that, 
COPD patients with worse disease status, i.e. lower FEV1, more signs of hyperinflation, lower exercise capacity 
and worse quadriceps force improved more in endurance exercise capacity after pulmonary rehabilitation and 
should not be excluded for treatment with pulmonary rehabilitation. Bratås et al (2010) in Norway found that 
patients with moderate disease were more likely to achieve an improved QOL than patients with severe disease. 
Wedzicha et al (1998) in UK found that patients with a high degree of dyspnea obtained less benefit from 
rehabilitation than patients with mild or moderate dyspnea. The authors speculated that it is possible that patients 
with more severe dyspnea may require longer or more intense training. These results are consistent with the 
meta-analysis of Salman et al    (2003) in USA who concluded that mild and moderate COPD (FEV1 > 35%) 
patients obtain benefits from short and long rehabilitation programs while severe COPD (FEV1 ≤ 35%) patients 
need at least 6 month of rehabilitation. Ergün et al (2011) added that FVC improved significantly only in earlier 
stages of COPD and attributed that to the high degree of hyperinflation in the late disease stages. 
 
Conclusions and recommendations 
The results of the current study revealed that, patients with COPD whether in the moderate, severe or very severe 
COPD stages benefited from pulmonary rehabilitation program. Those patients in severe disease stage gained 
greater improvement in activity dimension of QOL and perceived dyspnea while very severe stage patients 
showed significant improvement in impact and total score of SGRQ. Moderate stage patients also gained greater 
improvement in functional capacity. Further studies with a large number of patients are needed to confirm these 
findings and that such studied should include other outcome measures, such as the number of exacerbations, the 
medication used and the cost benefit of home-based pulmonary rehabilitation program. Also, more studies 
needed to evaluate effectiveness of long-term follow up of pulmonary rehabilitation programs. 
 
Acknowledgement 
We would like to extend our deep thanks to all health personnel in the chest disease department of Mansoura 
University Hospital as well as the patients who agreed to participate in the study for their cooperation in the 
fulfillment of this work.  
 
References 
Ait-Khaled, N., Enarson, D., & Bousquet, J. (2001). Chronic respiratory diseases in developing countries: the 
burden and strategies for prevention and management. Bulletin of the World Health Organization, 79(10), 
971-979. 
Al Moamary, M.S. (2008). Experience with pulmonary rehabilitation program in a tertiary care center in Saudi 
Arabia. Saudi Med J, 29, 271-276. 
Journal of Education and Practice                                                                                                                                                      www.iiste.org 
ISSN 2222-1735 (Paper)   ISSN 2222-288X (Online) 
Vol.4, No.15, 2013 
 
85 
Altenburg, W.A., de Greef, M., & ten Hacken, N. (2011). A better response in exercise capacity after pulmonary 
rehabilitation in more severe COPD patients. Respir Med, 109, 1-7.  
Ambrosino, N., & and Simonds, A. (2007). The clinical management in extremely severe COPD. Respir Med, 
101,1613–1624.  
American Thoracic Society. (2002). ATS statement: guidelines for the six-min walk test. American Journal of 
Respiratory Critical Care Medicine, 166, 11-17. 
Anto, J.M., Vermeire, P., Vestbo, J., & Sunyer, J. (2001). Epidemiology of chronic obstructive pulmonary 
disease. European Respiratory Journal, 17, 982-994. 
Barnes, P.J. (2002). New treatment for chronic obstructive pulmonary disease. Nature Review Drug Discovery, 
1(6), 437-446. 
Barnett, M. (2008). Nursing management of chronic obstructive pulmonary disease. British Journal of Nursing, 
17(21), 1314-8. 
Beaumont, M., Reychler, G., & Le Ber-Moy, C. (2011).The effect of a pulmonary rehabilitation program in 
relation to the severity of COPD. Rev Mal Respir, 28(3), 297-305. 
Borg, G. (1982). Psychophysical bases of perceived exertion. Medicine and Science Sports and Exercise Journal, 
14, 377-381.  
Bourbeau, J., Julien, M., & Maltais, F. (2003).  Reduction of hospital utilization in patients with chronic 
obstructive pulmonary disease: a disease-specific self-management intervention. Archives of Internal 
Medicine, 163(5), 585-591. 
Bratås, O., Espnes, G.A., & Rannestad, T. (2010). Pulmonary rehabilitation reduces depression and enhances 
health-related quality of life in COPD patients—especially in patients with mild or moderate disease. Chron 
Respir Dis J, 7(4), 229-237. 
Casaburi, R., Porszasz, J., & Burns, M.R. (1997). Physiologic benefits of exercise training in rehabilitation of 
patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 155, 1541-1551. 
Celli, B.R. (2000). The importance of spirometry in COPD and asthma: effect on approach to management. 
Chest, 117, 15S-19S.  
Ergün, P., Kaymaz, D., Günay, E., Erdoğan, Y., Turay, K., Demir, N., Çanak, E., Sengül, F., Egesel, N., & Köse, 
S.K. (2011). Comprehensive out-patient pulmonary rehabilitation: Treatment outcomes in early and late 
stages of chronic obstructive pulmonary disease. Ann Thorac Med, 6(2), 70–76. 
Garvey, C. (2001). Pulmonary rehabilitation for the elderly client. Advanced Practice Nursing Journal, 1(2), 321-
328 
Global Initiative for Chronic Obstructive Lung Disease. (2010).Global strategy for diagnosis, management and 
prevention of COPD. Available at http: //www.goldcopd.com. [accessed: 20.02.2010]. 
Hesselink, A.E., Pennix, B., & van der Windt, D. (2004). Effectiveness of an education programme by a general 
practice assistant for asthma and COPD patients: results from a randomized controlled trial. Patient 
education and counseling Journal, 55, 121-128. 
Hoeman, S.P. (2008). Rehabilitation Nursing: prevention, intervention, and outcome. 4th ed. USA: Mosby 
Company, 304-333. 
Hogg, J.C. (2004). Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet, 364, 
709-721. 
Hunter, M.H., & King, D.E. (2001). COPD: management of acute exacerbations and chronic stable disease. 
American Family Physician, 64(4), 603-611. 
Jones, P.W., Quirk, F.H., Baveystock, C.M., & Littlejohns, P. (1992). A self-complete measure for chronic 
airflow limitation- St George's Respiratory Questionnaire. American Review Respiratory Disease, 145, 
1321-1327.  
Karapolat, H., Atasever, A., Atamaz, F., Kirazh, Y., Elmas, F., & Erdinc, E. (2007).  Do the benefits gained using 
a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung, 185, 221-
225. 
Lotters, F., van Tol, B., & Kwakkel, G. (2002). Effects of controlled inspiratory muscle training in patients with 
COPD: a meta-analysis. Eur Respir J, 20, 570-576.  
Maltais, F., Bourbeau, J., & Shapiro, S. (2008). Chronic obstructive pulmonary disease axis of respiratory health 
network, Fonds de recherché en santé du Québec. Effects of home-based pulmonary rehabilitation in 
patients with chronic obstructive pulmonary disease: A randomized trial. Ann Inern Med, 149, 869-878.   
McCann, J.A., & Moreau, D. (2003). Handbook of geriatric nursing care (2nd ed.). Philadelphia: Lippincott 
Company, 176-189. 
Miller, C.A. (2009). Nursing for wellness in older adult.5th ed. Philadelphia: Lippincott Williams and Wilkins 
Company, 447-453. 
Niederman, M.S., Clemente, P.H., & Fein, A.M. (1991). Benefits of a multidisciplinary pulmonary rehabilitation 
Journal of Education and Practice                                                                                                                                                      www.iiste.org 
ISSN 2222-1735 (Paper)   ISSN 2222-288X (Online) 
Vol.4, No.15, 2013 
 
86 
program: improvements are independent of lung function. Chest, 99, 798-804. 
Nield, M.A., Soo Hoo, G.W., & Roper, J.M. (2007). Efficacy of pursed-lips breathing pattern retraining strategy 
for dyspnea reduction. J Cardiopulm Rehabil Prev, 27(4), 237-244. 
Norweg, A.M., Whiteson, J., & Malgady, R. (2005). The effectiveness of different combinations of pulmonary 
rehabilitation program components: a randomized controlled trial. Chest, 128, 663-672. 
Persson, I., Olsni, L., & Lagerstedt, M. (2000). Effects of an outpatient pulmonary rehabilitation program on 
quality of life and physical performance in patients with chronic obstructive pulmonary disease. 
Physiotherapy Theory and Practice, 16, 195-201.  
Peruzza, S., Sergi, S., Vianello, A.,  & Coin, A. (2003). COPD in elderly subjects: impact on functional status 
and quality of life. Respiratory Medicine, 97: 612-617. 
Phipps, W.J., Monahan, F.D., & Sands, J.K. (2003). Medical-Surgical Nursing: health and illness perspectives 
(7th ed.) London: Mosby Company, 566-580. 
Potter, P.A., & Perry, A.G. (2005). Fundamentals of nursing. 6th ed. USA: Mosby Company,1066-1133. 
Rennard, S.I. (2004). Treatment of stable COPD. Lancet, 364, 791-802. 
Resqueti, V., Gorostiza, A., & Gladis, J. (2007). Benefits of a home-based pulmonary rehabilitation program for 
patients with severe COPD. Arch Bronconeumol, 43(11), 599-604.  
Ries, A.l., Bauldoff, G.S., & Carlin, B.W. (2007). Pulmonary rehabilitation: joint ACCP/AACVPR evidence-
based clinical practice guidelines. Chest, 131, 4S-42S. 
Roach, S.S. (2001). Introductory gerontological nursing. Philadelphia: Lippincott Company, 263-269. 
Romagnoli, M., Dell’Orso, D., & Lorenzi, C. (2006). Repeated pulmonary rehabilitation in severe and disabled 
COPD patients. Respiration, 73, 769–776. 
Salman, G.F., Mosier, M.C., Beasley, B.W. (2003). Rehabilitation for patients with chronic obstructive 
pulmonary disease: Meta analysis of randomized controlled trials. J Gen Intern Med, 18, 213-221. 
Takigawa, N., Tada, A., Soda, R. (2007). Comprehensive pulmonary rehabilitation according to severity of 
COPD. Respir Med, 101, 326-332. 
Touhy, T.A., & Jett, K.F. (2010).  Ebersole& Hess' Gerontological Nursing and Healthy Aging .3rd ed. Canada: 
Mosby Company, 310-316.  
Vogiatzis, I., Williamson, A.F., Miles, J. (1991). Physiological response to moderate exercise workloads in a 
pulmonary rehabilitation program in patients with varying degrees of airflow obstruction. Chest, 116, 1200-
1207. 
Weaver, L.E., Richmond, T.S., & Vage, G.L. (1997). An explanatory model of functional status in chronic 
obstructive pulmonary disease. Nursing Research, 46, 26-31.  
Wedzicha, J.A., Bestall, J.C., & Garrod, R. (1998). Randomized controlled trial of pulmonary rehabilitation in 
severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir 
J, 12, 363-369. 
Wold, G.H. (2004). Basic geriatric nursing.3rd ed. USA: Mosby Company, 31-35. 
Yohannes, A.M. (2005). Depression and COPD in older people: a review discussion. Journal of British 
Community Nursing, 10(1), 42-46. 
 
 
 
  
This academic article was published by The International Institute for Science, 
Technology and Education (IISTE).  The IISTE is a pioneer in the Open Access 
Publishing service based in the U.S. and Europe.  The aim of the institute is 
Accelerating Global Knowledge Sharing. 
 
More information about the publisher can be found in the IISTE’s homepage:  
http://www.iiste.org 
 
CALL FOR PAPERS 
The IISTE is currently hosting more than 30 peer-reviewed academic journals and 
collaborating with academic institutions around the world.  There’s no deadline for 
submission.  Prospective authors of IISTE journals can find the submission 
instruction on the following page: http://www.iiste.org/Journals/ 
The IISTE editorial team promises to the review and publish all the qualified 
submissions in a fast manner. All the journals articles are available online to the 
readers all over the world without financial, legal, or technical barriers other than 
those inseparable from gaining access to the internet itself. Printed version of the 
journals is also available upon request of readers and authors.  
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische 
Zeitschriftenbibliothek EZB, Open J-Gate, OCLC WorldCat, Universe Digtial 
Library , NewJour, Google Scholar 
 
 
